Tatva Chintan Pharma Receives Sebi Nod For Rs 450 crore IPO
Monday, July 12, 2021
Comment
Tatva Chintan Pharma IPO: The IPO will consist of fresh issuance of shares worth Rs 225 crore and an offer of sale worth Rs 225 crore by existing promoters and shareholders
from NDTV Profit - Latest https://ift.tt/3e6mGeI
from NDTV Profit - Latest https://ift.tt/3e6mGeI
0 Response to "Tatva Chintan Pharma Receives Sebi Nod For Rs 450 crore IPO"
Post a Comment